Research progress of PET/CT radiomics in immunotherapy for non-small cell lung cancer
10.3760/cma.j.cn321828-20240926-00334
- VernacularTitle:PET/CT影像组学在非小细胞肺癌免疫治疗中的研究进展
- Author:
Boren JIA
1
;
Caozhe CUI
;
Yangyang ZHANG
;
Xinchao WANG
;
Ling YUAN
;
Zhifang WU
Author Information
1. 山西医科大学第一医院核医学科、分子影像精准诊疗省部共建协同创新中心，太原 030001
- Publication Type:Journal Article
- Keywords:
Carcinoma, non-small-cell lung;
Immunotherapy;
Radiomics;
Positron-emission tomography;
Tomography, X-ray computed;
Fluorodeoxyglucose F18;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2025;45(7):430-434
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, immunotherapy has become another important treatment for non-small cell lung cancer (NSCLC) after surgery, radiotherapy, chemotherapy and targeted therapy. As an emerging non-invasive tool, PET/CT radiomics provides a new way for precise diagnosis and treatment of NSCLC by quantitatively analyzing the metabolic and structural characteristics of tumors, demonstrating significant promise for applications in NSCLC immunotherapy. This article aims to review the research progress of PET/CT radiomics in NSCLC immunotherapy and to explore its potential value in predicting biomarkers, therapeutic efficacy, adverse effects, and evaluating prognosis.
